|
|
 |
Hospital Ethos・Basic Policies |
| We set Mission, Core Values and Vision as hospital ethos and basic policies aiming to be the ideal hospital specialized in cancer treatment and torchbearer for the future. |
| Based on these Ethos and basic policies, we provide the best treatment and health care service in a gentle and sincere manner and with dignity of patient rights. |
|
Hospital Ethos・Basic Policies |
| Mission ･･･ |
Aiming to Improve the Well-being of People Everywhere by Achieving Better Cancer Control |
| Core Values ･･･ |
Creativity, Quality, Sincerity, Cooperation |
| Vision ･･･ |
Become a World-Leading Hospital in Cancer Diagnosis and Treatment |
|
|
| 1. |
Strive to develop new cancer treatments. |
| 2. |
Provide safe and high-quality cancer treatment. |
| 3. |
Conduct cancer treatment in kind and gentle ways with consideration for the patient. |
| 4. |
Perform multi-disciplinary treatment based on individual organ specific diagnosis. |
| 5. |
Strive to foster medical personnel with strong sense of humanity. |
|
|
|
Patient Rights |
| 1. |
Based on fundamental human rights, you can receive a high- quality treatment.
(Fundamental Human Right)
|
| 2. |
You can receive a detailed explanation and information.
(Detailed Explanation and Information Service) |
| 3. |
You can receive treatment based on your own will.
(Self-determination for the Treatment) |
| 4. |
You have a right to know your diagnosis.
(Disclosure of Information) |
| 5. |
Private Information and Medical Information are fully protected and kept in secret.
(Protection of Private Information) |
|
| For example… |
| ※ You can ask for second opinion consultation. |
| ※ You can ask for consultation and also refuse to receive it. |
| ※ On the other hand, remember that you are responsible for your decision. |
| ※ If you want to know your diagnosis and record of treatment, please inquire explanation and disclosure of information. |
|
| Besides, we appreciate your understanding that we may ask you the participation into clinical trial necessary for development of new treatment. |
|
|
 |
|
|
|
